about
Natural Compounds for the Treatment of Psoriatic Arthritis: A Proposal Based on Multi-Targeted Osteoclastic Regulation and on a Preclinical StudyLuteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades.The emerging role of Hippo signaling pathway in regulating osteoclast formation.Cyanidin Chloride inhibits ovariectomy-induced osteoporosis by suppressing RANKL-mediated osteoclastogenesis and associated signaling pathways.Achyranthes bidentata polysaccharide suppresses osteoclastogenesis and bone resorption via inhibiting RANKL signaling.Carnosic acid inhibits inflammation response and joint destruction on osteoclasts, fibroblast-like synoviocytes, and collagen-induced arthritis rats.EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis.Helvolic acid attenuates osteoclast formation and function via suppressing RANKL-induced NFATc1 activationMadecassoside inhibits estrogen deficiency-induced osteoporosis by suppressing RANKL-induced osteoclastogenesisThe Effect of Exercise on the Prevention of Osteoporosis and Bone AngiogenesisCistanche deserticola polysaccharide attenuates osteoclastogenesis and bone resorption via inhibiting RANKL signaling and reactive oxygen species productionMolecular structure, expression, and functional role of Clec11a in skeletal biology and cancersEllagic acid protects ovariectomy-induced bone loss in mice by inhibiting osteoclast differentiation and bone resorptionThe emerging roles of hnRNPKDiosmetin inhibits osteoclast formation and differentiation and prevents LPS-induced osteolysis in miceCajaninstilbene acid inhibits osteoporosis through suppressing osteoclast formation and RANKL-induced signaling pathwaysScutellarein inhibits RANKL-induced osteoclast formation in vitro and prevents LPS-induced bone loss in vivoAstilbin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesisAsperpyrone A attenuates RANKL-induced osteoclast formation through inhibiting NFATc1, Ca2+ signalling and oxidative stressMiR-214 is an important regulator of the musculoskeletal metabolism and diseaseModulating calcium-mediated NFATc1 and mitogen-activated protein kinase deactivation underlies the inhibitory effects of kavain on osteoclastogenesis and bone resorptionPectolinarigenin prevents bone loss in ovariectomized mice and inhibits RANKL-induced osteoclastogenesis via blocking activation of MAPK and NFATc1 signalingVaccarin prevents titanium particle-induced osteolysis and inhibits RANKL-induced osteoclastogenesis by blocking NF-κB and MAPK signaling pathwaysSalidroside promotes rat spinal cord injury recovery by inhibiting inflammatory cytokine expression and NF-κB and MAPK signaling pathwaysAsiaticoside, a component of Centella asiatica attenuates RANKL-induced osteoclastogenesis via NFATc1 and NF-κB signaling pathwaysHymenialdisine: a marine natural product acts on both osteoblasts and osteoclasts and prevents estrogen-dependent bone loss in miceOsthole inhibits osteoclasts formation and bone resorption by regulating NF-κB signaling and NFATc1 activations stimulated by RANKLChondromodulin-1 in health, osteoarthritis, cancer, and heart diseaseTiliroside is a new potential therapeutic drug for osteoporosis in miceDaphnetin attenuates LPS-induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathwaysProtein Cytl1: its role in chondrogenesis, cartilage homeostasis, and diseaseMolecular structure and the role of high-temperature requirement protein 1 in skeletal disorders and cancersRhoifolin ameliorates titanium particle-stimulated osteolysis and attenuates osteoclastogenesis via RANKL-induced NF-κB and MAPK pathwaysDracorhodin perchlorate inhibits osteoclastogenesis through repressing RANKL-stimulated NFATc1 activityCepharanthine suppresses osteoclast formation by modulating the nuclear factor-κB and nuclear factor of activated T-cell signaling pathwaysEvodiamine inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in mice
P50
Q38658975-E211A1C1-0E43-4B89-87C4-9203DCA34BE3Q40145765-7486F328-7C06-4DC2-B3CC-6D681F69F859Q47316032-4040C9F4-81EA-4157-8ECB-28EB1E77E023Q47995224-AE1858DF-96C6-4540-B613-FD2C7052F9A1Q49973293-3ABB68C6-9759-44C6-83F9-1EAE7A6BBC30Q52665008-E10AA9A9-023E-4B0E-B56E-22A6F7DAD3BDQ55456799-BEEEB945-436E-488D-BA5D-5377C5896637Q57808358-E5E5A773-6813-4E0D-BF36-90646255F353Q58588319-705F1243-4E03-4F8C-ABC3-1A16B70622DBQ64240571-8BD8918F-A6AA-480F-A51B-849D103FEC04Q89400939-844BB755-F8C1-4169-AE0B-CC3A4D222B0DQ89461073-D48DD2C2-8050-4435-A6D2-402A7BF61339Q89566899-BBA9A7ED-27BD-4EBD-BA4C-6AE252B066D4Q90185616-B54ADFDF-AB1B-4A76-96B0-DAFE34C6003BQ90265896-B5BEA058-1B22-4D44-A3B4-B1D1DDA540A5Q90265992-C5EFA557-6A64-42D7-9C4A-CAD5383F5781Q90533883-F53DDD96-60F2-44DB-A4B1-59CFDDBD312CQ90653768-8387D346-735A-4926-B76E-BB04A52C49F7Q90709611-037011DD-4B42-4ACB-BF04-C678E724D3F0Q90750055-A37A40ED-E157-4CA5-840A-50A14573E471Q90758563-91FE7D2F-051C-4113-90AE-C72908B36FFFQ91000138-F1905F46-32CF-489A-A8AE-EFD491F297F9Q91022649-FEE7DA47-9FC8-4DE0-99AA-64D66F2C0B33Q91105129-1157DC9A-269E-4636-B37B-BD5A0F9B76EFQ91148292-90EAA736-02EE-4892-822C-0543EDD24F0EQ91894889-A6186DEC-D5F5-4553-8392-19B7BD7C5EFBQ91972723-FB907F40-5F7F-4A20-BEBC-3E99368960E1Q91977180-615E6CAE-9499-46C4-BBEE-D96C1704D76EQ91993992-99E0C36F-3AB8-49B4-B5C0-5A53ADFE63F3Q91994289-3408420E-58DB-4BFC-A510-977F0211D246Q92026618-91639747-2EF7-40EB-8F70-666C331D7984Q92195947-5F89BCCD-BBCD-470B-853E-378ACE83BE32Q92259696-FCFCC47E-9671-4718-BB49-6D7DEF679419Q92832466-B86E6E2F-45C0-4C17-B30A-81996F4F5B2CQ93063877-D54ED518-6B71-4EB3-8871-C8DD705C1F11Q93206720-CB1706BB-3A2F-4576-A6B0-35C7DB88F071
P50
description
researcher
@en
name
Jiake Xu
@en
type
label
Jiake Xu
@en
prefLabel
Jiake Xu
@en
P31
P496
0000-0003-2021-8309